Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis (Q73147752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R H Hardwick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C P Barham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Ozua

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P V Newcomb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Savage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Rahamin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Alderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Surgical Oncology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

30-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

An audit of the treatment of cancer of the oesophagus

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Cancer of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

1 reference

7 January 2021

Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Identification of heregulin, a specific activator of p185erbB2

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material.

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Expression of C-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for C-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

c-erbB-2 oncogene product expression and prognosis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Tumor suppressor genes in the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

P53 in tumour pathology: can we trust immunocytochemistry?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 function and dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 accumulation in ovarian carcinomas and its prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 expression and prognosis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 protein expression and prognosis in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Oesophagogastrectomy for carcinoma of the oesophagus and cardia

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

TNM classification of malignant tumors. A comparison between the new (1987) and the old editions

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Preoperative hyperthermia combined with chemotherapy and irradiation for the treatment of patients with esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Operable squamous esophageal cancer: current results from the East

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Is Barrett's metaplasia the source of adenocarcinomas of the cardia?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Adenocarcinoma of the esophagogastric junction and Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Cancer progression and p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Expression of desmoglein I in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0748-7983%2897%2980139-4

7 January 2021

10.1016/S0748-7983(97)80139-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066744%20AND%20SRC:MED&resulttype=core&format=json